Insider Transactions in Q4 2023 at Edwards Lifesciences Corp (EW)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,510
-42.98%
|
$1,102,760
$76.55 P/Share
|
|
Dec 29
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,510
+30.06%
|
$522,360
$36.75 P/Share
|
|
Dec 15
2023
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
7,000
-22.62%
|
$546,000
$78.25 P/Share
|
|
Dec 15
2023
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+18.45%
|
$413,000
$59.26 P/Share
|
|
Dec 13
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-31.89%
|
$2,171,900
$74.56 P/Share
|
|
Dec 13
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
Dec 13
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,658
-3.89%
|
$614,718
$71.86 P/Share
|
|
Dec 13
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,658
+3.75%
|
$389,610
$45.28 P/Share
|
|
Dec 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
8,000
-16.84%
|
$568,000
$71.86 P/Share
|
|
Dec 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+14.41%
|
$288,000
$36.75 P/Share
|
|
Dec 06
2023
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
3,500
-12.75%
|
$245,000
$70.0 P/Share
|
|
Dec 06
2023
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.31%
|
$206,500
$59.26 P/Share
|
|
Nov 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
6,000
-6.81%
|
$390,000
$65.19 P/Share
|
|
Nov 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+11.65%
|
$216,000
$36.75 P/Share
|
|
Nov 13
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,660
-1.31%
|
$562,900
$65.51 P/Share
|
|
Nov 13
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,660
+3.75%
|
$389,700
$45.28 P/Share
|
|
Nov 06
2023
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
371,689
+8.43%
|
-
|
|
Nov 06
2023
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Indirect |
371,689
-100.0%
|
-
|
|
Nov 03
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-86.74%
|
$1,966,450
$67.18 P/Share
|
|
Nov 03
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|
|
Oct 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,255
-27.37%
|
$449,810
$62.66 P/Share
|
|
Oct 31
2023
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,255
+21.49%
|
$261,180
$36.75 P/Share
|
|
Oct 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
5,000
-5.78%
|
$345,000
$69.92 P/Share
|
|
Oct 13
2023
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.1%
|
$180,000
$36.75 P/Share
|
|
Oct 13
2023
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
8,660
-1.97%
|
$597,540
$69.94 P/Share
|
|
Oct 13
2023
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
8,660
+3.75%
|
$389,700
$45.28 P/Share
|
|
Oct 10
2023
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
5,000
-12.56%
|
$360,000
$72.68 P/Share
|
|
Oct 10
2023
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.16%
|
$180,000
$36.75 P/Share
|
|
Oct 03
2023
|
Daveen Chopra CVP, TMTT |
SELL
Open market or private sale
|
Direct |
8,500
-26.19%
|
$595,000
$70.0 P/Share
|
|
Oct 03
2023
|
Daveen Chopra CVP, TMTT |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+20.76%
|
$501,500
$59.26 P/Share
|
|
Oct 02
2023
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
29,350
-86.74%
|
$1,995,800
$68.84 P/Share
|
|
Oct 02
2023
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,350
+46.45%
|
$1,056,600
$36.75 P/Share
|